DANBURY, Conn., Aug. 1, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) will issue its third quarter fiscal year 2012 financial results on August 8, 2012. Following the release of the company's financial results, Biodel's senior management will host a conference call to discuss the results and provide an update on the company's progress.
Interested parties may access a live audio webcast of the conference call in the investor section of Biodel's website at www.biodel.com. The audio webcast will be archived and available for replay through the website. Interested parties may also access an audio replay by dialing (855) 859-2056 (US) or (404) 537-3406 (International) and entering conference ID number 15900969.
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles.
CONTACT: Seth D. Lewis, +1-646-378-2952